Abstract: Antibody fragments, especially single-chain Fv fragments, have been established for the generation of immunoliposomes for targeted drug delivery in cancer therapy and other applications. Bispecific immunoliposomes should be useful for dual targeting addressing inter- and intratumoral heterogeneity of tumor antigen expression. Here, we established a protocol to generate dual-targeted immunoliposomes using genetically engineered scFv molecules recognizing two different tumor-associated antigens, EGFR and CEA (CEACAM5), applying a step-wise insertion of antibody-coupled micelles into preformed PEGylated liposomes. The dual-targeted immunoliposomes retained binding activity for both antigens and combined the selectivity of both antibodies within one liposome. Thus, these dual-targeted immunoliposomes should be suitable to deliver therapeutic payloads to tumor cells expressing EGFR or CEA, or both antigens.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Mack, K.; Rüger, R.; Fellermeier, S.; Seifert, O.; Kontermann, R.E. Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes. Antibodies 2012, 1, 199-214.
Mack K, Rüger R, Fellermeier S, Seifert O, Kontermann RE. Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes. Antibodies. 2012; 1(2):199-214.
Mack, Katharina; Rüger, Ronny; Fellermeier, Sina; Seifert, Oliver; Kontermann, Roland E. 2012. "Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes." Antibodies 1, no. 2: 199-214.